Renal complications of Fabry disease in children

Behzad Najafian, Michael Mauer, Robert J. Hopkin, Einar Svarstad

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Abstract

Fabry disease is an X-linked α-galactosidase A deficiency, resulting in accumulation of glycosphingolipids, especially globotriaosylceramide, in cells in different organs in the body. Renal failure is a serious complication of this disease. Fabry nephropathy lesions are present and progress in childhood while the disease commonly remains silent by routine clinical measures. Early and timely diagnosis of Fabry nephropathy is crucial since late initiation of enzyme replacement therapy may not halt progressive renal dysfunction. This may be challenging due to difficulties in diagnosis of Fabry disease in children and absence of a sensitive non-invasive biomarker of early Fabry nephropathy. Accurate measurement of glomerular filtration rate and regular assessment for proteinuria and microalbuminuria are useful, though not sensitive enough to detect early lesions in the kidney. Recent studies support the value of renal biopsy in providing histological information relevant to kidney function and prognosis, and renal biopsy could potentially be used to guide treatment decisions in young Fabry patients. This review aims to provide an update of the current understanding, challenges, and needs to better approach renal complications of Fabry disease in children.

Original languageEnglish (US)
Pages (from-to)679-687
Number of pages9
JournalPediatric Nephrology
Volume28
Issue number5
DOIs
StatePublished - May 2013

Bibliographical note

Funding Information:
This work was supported by grants from NIH (5U54NS065768-02) and Genzyme Corporation, a Sanofi company.

Keywords

  • Enzyme replacement therapy
  • Fabry
  • Fabry nephropathy
  • Kidney biopsy
  • Pediatrics

Fingerprint

Dive into the research topics of 'Renal complications of Fabry disease in children'. Together they form a unique fingerprint.

Cite this